Glistenings and PCO Evaluation for the Envista MX60

Democritus University of Thrace

Status: Completed

Conditions: Cataract

Treatments: Procedure: Phacoemulsification

Study type: Observational

Funder types: Other

Identifiers

NCT02698943

320/2-3-2016

Details and patient eligibility

About

Posterior capsule opacification (PCO) and glistenings development is among the primary reasons for sub-optimal visual capacity following cataract extraction surgery. Primary objective of this study is to evaluate the incidence of PCO and glistenings of the popular envista MX-60 intraocular lens (Bausch + Lomb) in a random sample of cataract patients who underwent phacoemulsification at least 1 year prior to their enrollment at the study

Enrollment: 60 patients

Sex: All

Ages: 60 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Diagnosis of senile cataract with stage 3 nuclear opalescence according to the Lens Opacities Classification System III (LOCS-3) grading scale

Exclusion criteria

Endothelial cell count less than 1900, glaucoma, IOP-lowering medications, former incisional surgery, former diagnosis of corneal disease, diabetes or autoimmune diseases

Trial design

60 participants in 1 patient group

Study Group

Description:

Participants who underwent phacoemulsification surgery and implantation of the Envista MX-60 IOL

Treatment:

Procedure: Phacoemulsification